Latest edition: Sunday, November 8, 2026, 7:12 pm
Carnet de Séance
Les sociétés cotées, chaque jour au plus fort de la séance
Ratings over the last 30 days: 0 positive, 1 neutral, 0 negative
TPR
On 6 November 2026, Tapestry (TPR) shares were up after the release of its quarterly results, according to Investing.com France. The detailed figures from the release were not available in the information consulted.
AMS.MC
On 6 November 2026, Amadeus published earnings in line with market expectations. The group maintained its 2026 guidance, placing it at the low end of the range, according to Zonebourse Suisse.
PIRC.MI
On 6 November 2026, Pirelli shares rose sharply on the Milan stock exchange, according to Zonebourse Suisse. The tyre maker had published results above expectations and confirmed its guidance.
IAG.L
On 6 November 2026, the parent company of British Airways published quarterly results described as mixed. According to Boursorama, profits fell, but analysts remained confident.
DTG.DE
Daimler Truck announced on 6 November 2026 a sharp rise in profit for the third quarter. According to Boursorama, the fall in orders in North America tempered the good news.
7203.T
On 6 November 2026, Le Journal de l'Automobile reported that Toyota had raised its annual targets moderately. The outlet described a carmaker that remained solid.
FWONK
On 6 November 2026, Goldman Sachs, UBS and BofA each raised their price target on Liberty Formula One (FWONK), according to Investing.com France. The reasons given differ: hospitality, F1 profits and results described as strong.
MAT
On 6 November 2026, Mattel published quarterly results seen as disappointing and cut its targets for the year, according to Bourse Direct. The detailed figures are not included in the available information.
UAA
On 6 November 2026, Under Armour lowered its full-year gross margin forecast, citing freight costs. According to Boursorama, the group also reduced its growth target and expected a greater impact in the Middle East.
MRNA
On 6 November 2026, Moderna raised its sales forecast for the year. According to the media, the group is relying on demand for Covid-19 vaccines abroad, after earnings that beat expectations.
